Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-871-3 | CAS number: 95193-59-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Type of information:
- other: toxicokinetic assessment
- Adequacy of study:
- key study
- Study period:
- July 2010 - August 2010
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Toxicokinetic assessment by a certified toxicologist
- Objective of study:
- absorption
- Qualifier:
- according to guideline
- Guideline:
- other: Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance
- Qualifier:
- according to guideline
- Guideline:
- other: ECB EU Technical Guidance Document on Risk Assessment, 2003
- GLP compliance:
- yes (incl. QA statement)
- Type:
- absorption
- Results:
- For risk assessment purposes: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%
- Conclusions:
- Interpretation of results (migrated information): other: the absorption factors for risk assessment purposes have been set by a certified toxicologist: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%
For risk assessment purposes:
oral absorption: 50%
inhalation absorption: 100%
dermal absorption: 10%
Reference
TOXICOKINETIC ASSESSMENT
The water solubility of Blown rapeseed oil is very low (< 1 mg/L). Since in general a compound needs to be dissolved before it can be taken up from the gastro-intestinal tract, it is unlikely that Blown rapeseed oil will show a high systemic exposure after oral administration. However, its highly lipophilic character (log Pow > 6) indicates that uptake by micellular solubilisation may be of particular importance. For risk assessment purposes oral absorption of Blown rapeseed oil is set at 50%. The results of the toxicity studies do not provide reasons to deviate from this proposed oral absorption factor.
Once absorbed, distribution throughout the body will be limited due to its low water solubility. Intracellular concentration is expected to be higher than extracellular concentration based on its lipophilic character. Absorbed Blown rapeseed oil might undergo conjugation. The conjugates will either be excreted via the bile (high molecular weights compounds) or the urine (low molecular weight compounds).
Due to the very low vapour pressure (< 1.33 x 10-8 Pa) and the high boiling point (reaction and/or decomposition at ≥350°C) it is not to be expected that Blown rapeseed oil will reach the nasopharyncheal region or subsequently the tracheobranchial or pulmonary region. If Blown rapeseed oil reaches the tracheobranchial region it is likely that uptake of Blown rapeseed oil by crossing the alveolar and capillary membranes will take place based on its highly lipophilic character (log Po/w > 6). However, the low water solubility of Blown rapeseed oil (< 1 mg/L) indicates that absorption from the respiratory tract will be limited. Overall, although it is unlikely that Blown rapeseed oil will be available to a high extent after inhalation via the lungs, for risk assessment purposes the inhalation absorption of Blown rapeseed oil is set at 100%.
Blown rapeseed oil being a liquid has the potential to partition from the stratum corneum into the epidermis. However, the highly lipophilic character (log Po/w > 6) and the low water solubility (< 1 mg/L) of the substance indicate that the transfer between the stratum corneum and the epidermis will be impaired. Although the data are insufficient (no molecular weight available) to meet the criteria for 10% dermal absorption as given in the TGD, a dermal absorption of 10% is proposed for risk assessment purposes based on the available information. The results of the toxicity studies do not provide reasons to deviate from this proposed dermal absorption factor.
Description of key information
Short description of key information on absorption rate:
The absorption factors for risk assessment purposes have been set by a certified toxicologist: dermal absorption 10%
Key value for chemical safety assessment
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
The absorption factors for risk assessment purposes have been set by a certified toxicologist: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%.
Once absorbed, distribution throughout the body will be limited due to its low water solubility. Intracellular concentration is expected to be higher than extracellular concentration based on its lipophilic character. Absorbed Blown rapeseed oil might undergo conjugation. The conjugates will either be excreted via the bile (high molecular weights compounds) or the urine (low molecular weight compounds).
Discussion on absorption rate:
Blown rapeseed oil being a liquid has the potential to partition from the stratum corneum into the epidermis. However, the highly lipophilic character (log Po/w > 6) and the low water solubility (< 1 mg/L) of the substance indicate that the transfer between the stratum corneum and the epidermis will be impaired. Although the data are insufficient (no molecular weight available) to meet the criteria for 10% dermal absorption as given in the TGD, a dermal absorption of 10% is proposed for risk assessment purposes based on the available information.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.